The FMCF receives operating funds from sources who periodically ask us to cite publications reporting data from our facility. full policy

To help keep user fees low please acknowledge our contribution in your publications. Then notify us so we can document these publications.

Please email references to

Feedback Survey

Your feedback is the single best way to help us improve our services.

You will be able to access the Sorting Feedback Survey through our online reservation portal and from within sorting appointment confirmation emails.

We look forward to hearing from you.

Using the facility


All individuals wishing to use the SickKids-UHN FMCF must first register with the facility. Learn more

Security Access

Physical access to the facility requires security card access. Learn more

Instrument Access

To use any of the analytical cytometers or the automated magnetic cell separator, users must receive training from FMCF staff.

To register for instrument training you will be required to:

  1. Obtain biosafety documents. This process can take some time and users are encouraged to ensure that their training documents are up-to-date. Learn more
  2. Submit training registration form and biosafety documents. Learn more

Booking and Cancellation Policies

Registered clients can visit Flow Cytometry iLab or Mass Cytometry iLab for FMCF Booking and Cancellation Policies.

Facility Acknowledgment Policy

The FMCF receives operating funds from several sources, allowing us to keep user fees low. Periodically our funding agencies ask us to cite publications reporting data from our facility. To help us show our funders that this facility has an important impact on your research productivity, please acknowledge our contribution in your publications, and notify us when you do this so that we can document these papers in our grant applications and renewals. Please email references to

A suggested acknowledgment is:
Flow and mass cytometry was performed in The SickKids-UHN Flow and Mass Cytometry Facility, with funding from the Ontario Institute for Cancer Research, McEwen Centre for Regenerative Medicine and the Canada Foundation for Innovation.